Neurobio Tech Revenue, Profits - NTII Annual Income Statement

Add to My Stocks
$0.01 $0.01 (50%) NTII stock closing price Sep 18, 2018 (Closing)

Looking at financial statements, along with the Neurobio Tech stock price, it's management, its economic moat, and industry competitors forms an important part of fundamental analysis. In the income statement, an investor can look at important parameters like revenue or sales, gross profits, net profits, and EPS basic to gain deeper insights. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has grown from 14.76M to 26.35M and how operating and non operating activities have impacted the NTII stock. Revenue for year 2009 is $26.35M and has increased from $14.76M year on year as is evident when you compare the latest figures in the latest Neurobio Tech profit and loss statement with those of the prior corresponding period. Also see Neurobio Tech assets and Neurobio Tech free cash flow for a complete valuation of NTII stock.

View revenue and profit details for latest and last 10 financial years.
show more
Fiscal year is Jul - Jun20092008
Neurobio Tech Revenues or Net Sales
Cost Of Goods Sold (COGS)--
Neurobio Tech Gross Profit
Research & Development Expense17.58M24.58M
Selling General & Admin Expense5.08M6.87M
Income Before Depreciation Depletion Amortization3.68M-16.69M
Depreciation Depletion Amortization--
Non Operating Income-0.56M2.85M
Interest Expense-2.47M
Neurobio Tech Pretax Income
Provision for Income Taxes--
Investment Gains Losses--
Other Income--
Income Before Extraordinaries & Disc Operations3.12M-16.32M
Extraordinary Items & Discontinued Operations--
Neurobio Tech Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS26.03M19.44M
Average Shares used to compute Basic EPS26.03M19.44M
Income Before Nonrecurring Items3.18M-16.32M
Income from Nonrecurring Items-0.06M-
Neurobio Tech Earnings Per Share Basic Net
Neurobio Tech Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items0.12-0.84
Preferred Dividends Acc Pd--
Dividends Common--
Dividend Per Share Common0.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.

Before investing one should read a report on Neurobio Tech stock analysis. It helps to look at the following income statement items:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $26.35M for this year of 2009. Our Neurobio Tech revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: Most businesses like Neurobio Tech try to grow their profits by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.

The income statement is also called the profit and loss statement. Apart from the NTII income statement, one can check the Neurobio Tech historical stock prices to check how the price has moved with time.

Neurobio Tech Income Statement - Key Financial Ratios

Annual Income Statements - Neurobiological Technologies, Inc. Industry Peers

Acusphere income statement, Celldex Therapeutics income statement, HST Global income statement, Pharmos income statement